What does COVID-19 mean for patients at high cardiovascular risk?

In this short podcast Professor Steven Nissen from the Cleveland Clinic in the United States gives his take on the potential impact of the COVID-19 pandemic on the management of patients at high cardiovascular risk. Taking part in the discussion, Professor Sophia Zoungas suggests ways to collaborate with patients to reach therapeutic decisions and to ensure they remain on therapy during this time.

This is an excerpt from a recent Amgen One Cardiovascular Academy live webcast, hosted by Professor Stephen Nicholls (MonashHeart), in conversation with Professor Steven Nissen (The Cleveland Clinic, Ohio, USA) and Professor Sophia Zoungas (Head of Monash University’s School of Public Health and Preventive Medicine).

the limbic · CV risk reduction: current status and future directions

Amgen One Cardiovascular Academy educational agenda is developed by an independent steering committee comprising Professor Stephen Nicholls, MonashHeart, VIC (Chair), Professor Gemma Figtree, Royal North Shore Hospital, NSW, Professor Anthony Keech, Royal Prince Alfred Hospital, NSW, Professor Karam Kostner, Mater Hospital, QLD, Professor Richard O’Brien, Austin Hospital, VIC, Associate Professor David Sullivan, Royal Prince Alfred Hospital, NSW, Professor Gerald Watts, University of Western Australia, WA and Professor Sophia Zoungas, Monash University, VIC.

Already a member?

Login to keep reading.

Email me a login link

© 2022 the limbic